Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Hepatocellular Carcinoma”

313 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 313 results

Testing effectiveness (Phase 2)Study completedNCT00614913
What this trial is testing

Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatocellular Carcinoma
Loma Linda University 76
Not applicableStudy completedNCT02774161
What this trial is testing

B-mode Ultrasound Imaging in Detecting Early Liver Cancer

Who this might be right for
CirrhosisEarly Hepatocellular CarcinomaFibrosis+2 more
Stanford University 45
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00077142
What this trial is testing

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 37
Early research (Phase 1)Not Yet RecruitingNCT06822985
What this trial is testing

QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Wan-Guang Zhang 21
Early research (Phase 1)UnknownNCT05281926
What this trial is testing

A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 10
Early research (Phase 1)Study completedNCT00441376
What this trial is testing

ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver

Who this might be right for
Hepatocellular CarcinomaLiver Neoplasms
Imunon 30
Early research (Phase 1)Study completedNCT01594125
What this trial is testing

Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Boehringer Ingelheim 30
Testing effectiveness (Phase 2)Study completedNCT01116635
What this trial is testing

Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of British Columbia 24
Early research (Phase 1)Study completedNCT02642913
What this trial is testing

Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
Memorial Sloan Kettering Cancer Center 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT06841185
What this trial is testing

Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX13 with YERVOY As a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Henlius Biotech 656
Testing effectiveness (Phase 2)Looking for participantsNCT06911255
What this trial is testing

Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)Unresectable Hepatocellular Carcinoma
Yoon Jun Kim 24
Early research (Phase 1)Not Yet RecruitingNCT07583316
What this trial is testing

First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Esophagus CancerHead and Neck Cancer+1 more
Corregene Biotechnology Co., Ltd 192
Early research (Phase 1)Ended earlyNCT00003147
What this trial is testing

Gene Therapy in Treating Patients With Cancer of The Liver

Who this might be right for
Liver Cancer
National Cancer Institute (NCI) 30
Early research (Phase 1)Ended earlyNCT04502082
What this trial is testing

Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasm+1 more
Eureka Therapeutics Inc. 8
Testing effectiveness (Phase 2)Ended earlyNCT00971126
What this trial is testing

Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Health Research Institutes, Taiwan 3
Early research (Phase 1)Study completedNCT01497444
What this trial is testing

Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney CancerLiver Cancer
Alliance for Clinical Trials in Oncology 24
Early research (Phase 1)Ended earlyNCT01521780
What this trial is testing

Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)

Who this might be right for
Hepatocellular Carcinoma
Merck Sharp & Dohme LLC 12
Early research (Phase 1)Temporarily pausedNCT00909558
What this trial is testing

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Envita Medical Center, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00321594
What this trial is testing

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 54
Next Page